Full Press Release Details
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences:
A formal presentation at the Stifel 2023 Healthcare Conference in New York at 4:10 p.m. ET on Tuesday, November 14, 2023. A live webcast will be available using this weblink: https://wsw.com/webcast/stifel83/celc/2056478; and
A fireside chat at the Jefferies London Healthcare Conference at 8:00 a.m. GMT / 4:00 a.m. ET on Thursday, November 16, 2023. A live webcast will be available using this weblink: https://wsw.com/webcast/jeff287/celc/1825156.
View source version of release on GlobeNewswire.com
Brian Sullivan, bsullivan@celcuity.com
Vicky Hahne, vhahne@celcuity.com
Maria Yonkoski, maria.yonkoski@westwicke.com